Position in ACHV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$387,709
+$180,800 QoQ
Shares Held
59,374
-15.6% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 111 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in ACHV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. ACHV ranks #285 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in ACHV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $387,709 | 59,374 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $206,909 | 70,378 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $392,931 | 79,061 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $105,987 | 33,647 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $240,229 | 106,297 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $168,576 | 63,138 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $268,275 | 76,215 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $429,731 | 90,661 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $154,051 | 32,777 | Shares | Defined | 2025-05-14 | |
| 2023-09-30 | $9,460 | 2,200 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $19,722 | 3,800 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $25,840 | 3,800 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $33,190 | 13,547 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,319 | 2,521 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,200 | 2,500 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $48,818 | 6,449 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $427,946 | 55,006 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $942,386 | 110,869 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,250,015 | 139,200 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $1,013,782 | 87,546 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8 | 1 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $133,241 | 15,919 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $8 | 22 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7 | 25 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||